CCR9 and acute lymphoblastic leukemia: We performed the DisGeNET GO enrichment analysis to get the disease phenotype associated with CCR9 overexpression and found its enrichment in leukemic pathways including precursor cell lymphoblastic leukemia, acute promyelocytic leukemia, and acute lymphocytic leukemia (Supplementary Figure S6A).